Synopsis
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
40
PharmaCompass offers a list of Ambroxol Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ambroxol Hydrochloride manufacturer or Ambroxol Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ambroxol Hydrochloride manufacturer or Ambroxol Hydrochloride supplier.
A Boehringer Ingelheim Brand of Ambroxol Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Boehringer Ingelheim Brand of Ambroxol Hydrochloride, including repackagers and relabelers. The FDA regulates Boehringer Ingelheim Brand of Ambroxol Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Boehringer Ingelheim Brand of Ambroxol Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Boehringer Ingelheim Brand of Ambroxol Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Boehringer Ingelheim Brand of Ambroxol Hydrochloride supplier is an individual or a company that provides Boehringer Ingelheim Brand of Ambroxol Hydrochloride active pharmaceutical ingredient (API) or Boehringer Ingelheim Brand of Ambroxol Hydrochloride finished formulations upon request. The Boehringer Ingelheim Brand of Ambroxol Hydrochloride suppliers may include Boehringer Ingelheim Brand of Ambroxol Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Boehringer Ingelheim Brand of Ambroxol Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Boehringer Ingelheim Brand of Ambroxol Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Boehringer Ingelheim Brand of Ambroxol Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Boehringer Ingelheim Brand of Ambroxol Hydrochloride DMFs exist exist since differing nations have different regulations, such as Boehringer Ingelheim Brand of Ambroxol Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Boehringer Ingelheim Brand of Ambroxol Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Boehringer Ingelheim Brand of Ambroxol Hydrochloride USDMF includes data on Boehringer Ingelheim Brand of Ambroxol Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Boehringer Ingelheim Brand of Ambroxol Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Boehringer Ingelheim Brand of Ambroxol Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Boehringer Ingelheim Brand of Ambroxol Hydrochloride Drug Master File in Japan (Boehringer Ingelheim Brand of Ambroxol Hydrochloride JDMF) empowers Boehringer Ingelheim Brand of Ambroxol Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Boehringer Ingelheim Brand of Ambroxol Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Boehringer Ingelheim Brand of Ambroxol Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Boehringer Ingelheim Brand of Ambroxol Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Boehringer Ingelheim Brand of Ambroxol Hydrochloride Drug Master File in Korea (Boehringer Ingelheim Brand of Ambroxol Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Boehringer Ingelheim Brand of Ambroxol Hydrochloride. The MFDS reviews the Boehringer Ingelheim Brand of Ambroxol Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Boehringer Ingelheim Brand of Ambroxol Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Boehringer Ingelheim Brand of Ambroxol Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Boehringer Ingelheim Brand of Ambroxol Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Boehringer Ingelheim Brand of Ambroxol Hydrochloride suppliers with KDMF on PharmaCompass.
A Boehringer Ingelheim Brand of Ambroxol Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Boehringer Ingelheim Brand of Ambroxol Hydrochloride Certificate of Suitability (COS). The purpose of a Boehringer Ingelheim Brand of Ambroxol Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Boehringer Ingelheim Brand of Ambroxol Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Boehringer Ingelheim Brand of Ambroxol Hydrochloride to their clients by showing that a Boehringer Ingelheim Brand of Ambroxol Hydrochloride CEP has been issued for it. The manufacturer submits a Boehringer Ingelheim Brand of Ambroxol Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Boehringer Ingelheim Brand of Ambroxol Hydrochloride CEP holder for the record. Additionally, the data presented in the Boehringer Ingelheim Brand of Ambroxol Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Boehringer Ingelheim Brand of Ambroxol Hydrochloride DMF.
A Boehringer Ingelheim Brand of Ambroxol Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Boehringer Ingelheim Brand of Ambroxol Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Boehringer Ingelheim Brand of Ambroxol Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Boehringer Ingelheim Brand of Ambroxol Hydrochloride written confirmation (Boehringer Ingelheim Brand of Ambroxol Hydrochloride WC) is an official document issued by a regulatory agency to a Boehringer Ingelheim Brand of Ambroxol Hydrochloride manufacturer, verifying that the manufacturing facility of a Boehringer Ingelheim Brand of Ambroxol Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Boehringer Ingelheim Brand of Ambroxol Hydrochloride APIs or Boehringer Ingelheim Brand of Ambroxol Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Boehringer Ingelheim Brand of Ambroxol Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Boehringer Ingelheim Brand of Ambroxol Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Boehringer Ingelheim Brand of Ambroxol Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Boehringer Ingelheim Brand of Ambroxol Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Boehringer Ingelheim Brand of Ambroxol Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Boehringer Ingelheim Brand of Ambroxol Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Boehringer Ingelheim Brand of Ambroxol Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Boehringer Ingelheim Brand of Ambroxol Hydrochloride suppliers with NDC on PharmaCompass.
Boehringer Ingelheim Brand of Ambroxol Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Boehringer Ingelheim Brand of Ambroxol Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Boehringer Ingelheim Brand of Ambroxol Hydrochloride GMP manufacturer or Boehringer Ingelheim Brand of Ambroxol Hydrochloride GMP API supplier for your needs.
A Boehringer Ingelheim Brand of Ambroxol Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Boehringer Ingelheim Brand of Ambroxol Hydrochloride's compliance with Boehringer Ingelheim Brand of Ambroxol Hydrochloride specifications and serves as a tool for batch-level quality control.
Boehringer Ingelheim Brand of Ambroxol Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Boehringer Ingelheim Brand of Ambroxol Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Boehringer Ingelheim Brand of Ambroxol Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Boehringer Ingelheim Brand of Ambroxol Hydrochloride EP), Boehringer Ingelheim Brand of Ambroxol Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Boehringer Ingelheim Brand of Ambroxol Hydrochloride USP).
